Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/30/2014 | CN103751242A Process for preparing extract of caralluma nebrownii plant |
04/30/2014 | CN103751237A Medicament of dsRNA and saikosaponin |
04/30/2014 | CN103751226A Application of Yishenkang Capsules in preparing medicaments for treating hepatitis |
04/30/2014 | CN103751221A Application of SIRT1 inhibitor and sorafenib in preparing medicaments for treating liver cancer |
04/30/2014 | CN103751219A Novel application of mixture of inorganic copper salt and silkworm excrement extract and mixture of sodium copper chlorophyllin and silkworm excrement extract in promoting thrombopoiesis |
04/30/2014 | CN103751217A Propolis-containing compound preparation |
04/30/2014 | CN103751211A Methods and pharmaceutical compositions for healing wounds |
04/30/2014 | CN103751210A Application of extracting solution of natural multi-form arsenic |
04/30/2014 | CN103751209A Prescription for treating cough |
04/30/2014 | CN103751207A Medicinal composition for treating Alzheimer's disease and application thereof |
04/30/2014 | CN103751206A Medicinal composition for preventing Alzheimer's disease and application thereof |
04/30/2014 | CN103751205A Medicinal composition for treating vascular dementia and application thereof |
04/30/2014 | CN103751204A Medicinal composition for preventing vascular dementia and application thereof |
04/30/2014 | CN103751203A Medicinal composition for treating essential hypertension and application thereof |
04/30/2014 | CN103751202A Application of Eucheuma gelatinae polysaccharide in preparing anti-herpes simplex virus medicament |
04/30/2014 | CN103751201A Anti-parasitic orally disintegrating tablet for dogs and cats and preparation method thereof |
04/30/2014 | CN103751200A Skin tinea eliminating cream |
04/30/2014 | CN103751199A Composite pesticide and preparation method thereof |
04/30/2014 | CN103751198A Absorption-promoting pharmaceutical composition ointment for treating skin diseases and preparation method thereof |
04/30/2014 | CN103751197A New use of stibene glucoside in preparing medicament for treating Alzheimer disease |
04/30/2014 | CN103751196A Ceftiofur hydroxypropyl-beta-cyclodextrin inclusion compound and preparation method thereof |
04/30/2014 | CN103751195A Method for treating oral ulcer |
04/30/2014 | CN103751194A Methods and compositions for treating disorders |
04/30/2014 | CN103751193A Pharmaceutical composition comprising linagliptin and optional SGLT2 inhibitor and uses thereof |
04/30/2014 | CN103751192A Pharmaceutical composition comprising linagliptin and optional SGLT2 inhibitor and uses thereof |
04/30/2014 | CN103751191A Combination medicine for treating psoriasis |
04/30/2014 | CN103751190A Application of triazole compound to preparation of acetaldehyde dehydrogenase 2 activator |
04/30/2014 | CN103751189A Pharmaceutical composition for treating rhinitis |
04/30/2014 | CN103751188A Sodium cromoglycate, naphazoline hydrochloride and chlorpheniramine maleate nasal spray |
04/30/2014 | CN103751187A Application of penehyclidine hydrochloride in treating mesenteric arterial embolism caused by septic shock |
04/30/2014 | CN103751186A Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
04/30/2014 | CN103751185A Application of L-oxiracetam and oxiracetam in preparing medicaments for preventing or treating coma |
04/30/2014 | CN103751184A Application of pregnane X receptor antagonist in preparation of lipid regulation and liver protection product |
04/30/2014 | CN103751183A Application of compound to medicines for treating renal insufficiency |
04/30/2014 | CN103751182A Application of compound to medicines for treating myocardial ischemia |
04/30/2014 | CN103751181A Application of compound to medicines for treating ischemic brain injury |
04/30/2014 | CN103751180A Application of compound to medicines for treating hemorrhagic fever with renal syndrome |
04/30/2014 | CN103751179A Application of compound to medicines for treating or preventing acute heart failure |
04/30/2014 | CN103751178A Trigoxyphin K application in thrombocyte increasing drugs |
04/30/2014 | CN103751177A Trigoxyphin K application in blood vessel expanding drugs |
04/30/2014 | CN103751176A Trigoxyphin K application in acute heart failure treatment or prevention drugs |
04/30/2014 | CN103751175A Application of Chukrasone B in vasodilation drugs |
04/30/2014 | CN103751174A Application of schisandra chinensis monomer compound in preparation of drugs for prevention and treatment of hepatotoxicity caused by acetaminophen |
04/30/2014 | CN103751173A Application of dihydromyricetin in preparation of liver regeneration medicine |
04/30/2014 | CN103751172A Application of dixanthone compounds in preparation of drugs for treating leukemia |
04/30/2014 | CN103751171A Novel natural anticancer medicine prepared by using dihydromyricetin cooperated organic acids as raw materials |
04/30/2014 | CN103751170A Trigoxyphin K application in rhinitis treatment drugs |
04/30/2014 | CN103751169A Application of 3'-methoxy benzyl-3,5-dimethoxy-4-(3'-methoxy benzyloxy)benzoate in preparation of drugs for treating or preventing rheumatoid arthritis |
04/30/2014 | CN103751168A Application of 3'-methoxy benzyl-4-hydroxy-3,5-dimethoxy-benzoate in preparation of drugs for treating or preventing rheumatoid arthritis |
04/30/2014 | CN103751167A Application of benzyl-4-hydroxy-3,5-dimethoxy benzoate in preparation of drugs for treating or preventing rheumatoid arthritis |
04/30/2014 | CN103751166A Application of benzyl-4-(benzyloxy)-dimethoxy benzoate in preparation of drugs for preventing and treating rheumatoid arthritis |
04/30/2014 | CN103751165A Application of 3,5-dimethoxy-4-(3'-methoxy benzyloxy)benzoate in preparation of drugs for treating acute inflammation |
04/30/2014 | CN103751164A Application of benzyl-4-(benzyloxy)-dimethoxy benzoate in preparation of drugs for treating acute inflammation |
04/30/2014 | CN103751163A Application of 3'-methoxy benzyl-3,5-dimethoxy-4-(3'-methoxy benzyloxy)benzoate |
04/30/2014 | CN103751162A Application of benzyl-4-hydroxy-3,5-dimethoxy benzoate in preparation of drugs for treating acute inflammation |
04/30/2014 | CN103751161A Application of 3'-methoxy benzyl-4-hydroxy-3,5-dimethoxy-benzoate in preparation of drugs for treating acute inflammation |
04/30/2014 | CN103751160A Application of 2-[3, 5-dihydroxy-2-(1-acyl) phenyl] acetate |
04/30/2014 | CN103751159A Application of syringic acid-(4-hydroxy-3,5-dimethoxybenzoic acid) in preparation of drugs for treating acute inflammation |
04/30/2014 | CN103751158A Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
04/30/2014 | CN103751157A Peptide compounds for treating refractory status epilepticus |
04/30/2014 | CN103751156A Piceatannol-containing composition, and drinking food and cosmetics containing piceatannol-containing composition |
04/30/2014 | CN103751155A Ornidazole oral cataplasm |
04/30/2014 | CN103751154A Ornidazole paster for transluminal administration |
04/30/2014 | CN103751153A Secnidazole biological adhesion patch with biological adhesion properties |
04/30/2014 | CN103751152A Amlexanox oral patch |
04/30/2014 | CN103751151A Venlafaxine slow-release formulation capable of providing 24-h release result and preparation method of venlafaxine slow-release formulation |
04/30/2014 | CN103751148A Targeting and slow-release antineoplastic medicine nanoparticle with amphiphilic polyurethane as carrier and preparation method thereof |
04/30/2014 | CN103751146A Vitamin E softgel and preparation method thereof |
04/30/2014 | CN103751145A Ornidazole capsule with improved uniformity |
04/30/2014 | CN103751144A Ornidazole vaginal effervescent tablet |
04/30/2014 | CN103751143A Secnidazole vaginal effervescence tablet |
04/30/2014 | CN103751142A Butoconazole nitrate vaginal effervescence tablet |
04/30/2014 | CN103751141A Rupatadine fumarate tablets and preparation method thereof |
04/30/2014 | CN103751140A Cabozantinib dispersible tablets and preparation method thereof |
04/30/2014 | CN103751139A Lurasidone orally disintegrating tablet |
04/30/2014 | CN103751138A Orally disintegrating tablet containing lasofoxifene tartrate and preparation method thereof |
04/30/2014 | CN103751137A Multi-cell ranolazine slow-release pellet tablet |
04/30/2014 | CN103751136A 维生素c片及其制备方法 Vitamin c tablets and its preparation method |
04/30/2014 | CN103751135A Zolmitriptan fast-release tablet and preparation method thereof |
04/30/2014 | CN103751134A Risperidone orally-disintegrating tablet |
04/30/2014 | CN103751133A Dipyridamole oral-disintegrating tablet |
04/30/2014 | CN103751132A Fluconazole dispersible tablet and preparation method thereof |
04/30/2014 | CN103751131A Ornidazole dripping pill |
04/30/2014 | CN103751130A Amlodipin dispersible tablet and preparation method thereof |
04/30/2014 | CN103751129A Secnidazole tablet with improved solubility |
04/30/2014 | CN103751128A Rapid-release fructose diphosphate sodium |
04/30/2014 | CN103751127A Novel telmisartan orally disintegrating tablet and preparation method thereof |
04/30/2014 | CN103751126A Azithromycin dispersible tablet with improved taste |
04/30/2014 | CN103751125A Domperidone orally disintegrating tablet and preparation method thereof |
04/30/2014 | CN103751123A Composite medicine comprising cefazolin |
04/30/2014 | CN103751122A 17beta-estradiol/PLGA sustained release microsphere and preparation method thereof |
04/30/2014 | CN103751121A Flucloxacillin sodium freeze-dried powder injection composition and preparation method thereof |
04/30/2014 | CN103751120A Method for preparing injection biapenem solid dispersion |
04/30/2014 | CN103751119A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
04/30/2014 | CN103751118A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
04/30/2014 | CN103751117A Carvedilol sustained-release capsule |
04/30/2014 | CN103751116A Preparation method of gentamicin sulphate-loading porous hydroxyapatite/PLGA (poly(DL-lactide-co-glycolide) microspheres |
04/30/2014 | CN103751115A Tetrahydropalmatine intra-gastric floating oral microsphere |
04/30/2014 | CN103751113A Etamsylate microsphere preparation and preparation method thereof |
04/30/2014 | CN103751112A Ranolazine sustained-release pellet and preparation form thereof |